Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof

Patent 11781138 was granted and assigned to Aro Biotherapeutics on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Oct, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 11 Oct, 2023
Edits made to:
Infobox (+49 properties)
Article (+180 characters)
‌

 US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof

Article

Patent abstract

The present disclosure relates to compositions, such as siRNA molecules and FN3 domains conjugated to the same, as well as methods of making and using the molecules.

Infobox
Is a
Patent
Patent
Patent Applicant
Aro Biotherapeutics
Aro Biotherapeutics
Current Assignee
Aro Biotherapeutics
Aro Biotherapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11781138
Patent Inventor Names
Karyn O'Neil
Robert Kolakowski
Russell C. Addis
Steven G. Nadler
Swapnil Kulkarni
Yao Xin
Zhanna Druzina
Date of Patent
October 10, 2023
Patent Application Number
17070337
Date Filed
October 14, 2020
Patent Citations
‌
US Patent 7115396 Protein scaffolds for antibody mimics and other binding proteins
‌
US Patent 7119171 Binding polypeptides
‌
US Patent 7153661 Artificial antibody polypeptides
‌
US Patent 7288638 Fully human antibodies against human 4-1BB
‌
US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type
‌
US Patent 7709214 Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1
‌
US Patent 7794710 Methods of enhancing T cell responsiveness
‌
US Patent 7842476 In vitro peptide expression library
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
‌
US Patent 8278419 Fibronectin type III domain based scaffold compositions, methods and uses
‌
US Patent 8293482 Fibronectin type III domain based scaffold compositions, methods and uses
‌
US Patent 8552154 Anti-PD-L1 antibodies and uses therefor
‌
US Patent 8569227 Stabilized fibronectin domain compositions, methods and uses
‌
US Patent 8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof
‌
US Patent 8779108 Targeted binding agents against B7-H1
‌
US Patent 8981063 B7-H1 Antibodies
‌
US Patent 9156887 Non-natural consensus albumin binding domains
‌
US Patent 9175082 Antigen binding proteins that bind PD-L1
‌
US Patent 9200273 Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
‌
US Patent 9212224 Antibodies that bind PD-L1 and uses thereof
‌
US Patent 9326941 High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same
‌
US Patent 9546368 Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
‌
US Patent 9644023 Compositions and methods for phagocyte delivery of anti-staphylococcal agents
‌
US Patent 9695228 EGFR and c-Met fibronectin type III domain binding molecules
‌
US Patent 9897612 Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
‌
US Patent 10196446 Cysteine engineered fibronectin type III domain binding molecules
‌
US Patent 10233448 Modified double-stranded RNA agents
‌
US Patent 10597438 PD-L1 binding fibronectin type III domains
‌
US Patent 10611823 CD137 binding fibronectin type III domains
‌
US Patent 10626165 CD8a-binding fibronectin type III domains
Patent Primary Examiner
‌
Brian Whiteman
CPC Code
‌
C12N 2310/14
‌
C12N 15/113

Find more entities like US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo